Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00236288 · ClinicalTrials.gov registry record · NA
A Feasibility Study of Smoking Cessation Program in Radiation Oncology
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT00236288 is a NA study that has completed, run by Indiana University. The registered enrollment target is 36 participants.
The verdict
NCT00236288, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
To test the feasibility of an intensive behavioral and pharmacologic tobacco cessation program for radiation oncology patients and their families/companions.
Interventions
- DRUG Bupropion and intensive behavioral therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2005-10 |
| Est. Completion | 2007-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00236288
The ClinicalTrials.gov registry entry for NCT00236288 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Bupropion and intensive behavioral therapy is the first listed.
NCT00236288 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00236288 about?
NCT00236288 is a clinical study titled "A Feasibility Study of Smoking Cessation Program in Radiation Oncology". To test the feasibility of an intensive behavioral and pharmacologic tobacco cessation program for radiation oncology patients and their families/companions.
What is the current status of trial NCT00236288?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2005-10. Estimated completion is 2007-04.
What interventions are being tested in trial NCT00236288?
The interventions under investigation include: Bupropion and intensive behavioral therapy (DRUG).
Who is sponsoring clinical trial NCT00236288?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.